Key statistics
Key statistics
- 700+ employees globally
- 4 sites (3 in India, 1 in US)
- 8 biosimilars commercialized in 5 years
- Delivered 30+ projects using EnzeneX™
- 10 months from gene to phase 1
- 8 weeks onboarding
- Up to 50% reduction in COGS and carbon footprint using EnzeneX™
- 10 times higher productivity and improved quality for complex proteins using EnzeneX™
- EU-GMP certified GMP sites in India
- USDA-FDA designed GMP facility in US
The future begins now
Your biologic deserves the most technologically advanced manufacturing process in the industry. And you deserve a new way to think about strategic partnership. Today is just the beginning.